Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Medtronic
Healthtrust
US Army
Cipla

Generated: August 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Louisiana Health Service & Indemnity Company d/b/a Blue Cross Blue Shield of Louisiana v. AbbVie Inc. (N.D. Ill. 2019)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Louisiana Health Service & Indemnity Company d/b/a Blue Cross Blue Shield of Louisiana v. AbbVie Inc. (N.D. Ill. 2019)

Docket   Try a Free Trial Date Filed 2019-04-30
Court District Court, N.D. Illinois Date Terminated
Cause 15:1 Antitrust Litigation Assigned To John Joseph Tharp Jr.
Jury Demand Plaintiff Referred To
Parties ABBVIE BIOTECHNOLOGY LTD; ABBVIE INC.; AMGEN INC.; HMO LOUISIANA, INC.; LOUISIANA HEALTH SERVICE & INDEMNITY COMPANY D/B/A BLUE CROSS BLUE SHIELD OF LOUISIANA
Patents 7,820,799; 8,093,045; 8,663,945; 8,911,964; 8,926,975; 8,961,973; 8,986,693; 9,018,361; 9,067,992; 9,090,689; 9,090,867; 9,096,666; 9,187,559; 9,255,143; 9,266,949; 9,359,434; 9,365,645; 9,512,216
Attorneys Elizabeth A. Fegan; Steve W. Berman
Firms Hagens Berman Sobol Shapiro LLP
Link to Docket External link to docket
Biologic Drugs cited in Louisiana Health Service & Indemnity Company d/b/a Blue Cross Blue Shield of Louisiana v. AbbVie Inc.
The biologic drugs covered by the patents cited in this case are   Try a Free Trial and   Try a Free Trial .

Details for Louisiana Health Service & Indemnity Company d/b/a Blue Cross Blue Shield of Louisiana v. AbbVie Inc. (N.D. Ill. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-04-30 1 Complaint Filed: 04/30/19 Page 41 of 85 PageID #:41 7,820,799. Although it does not specifically mention the…second patent not patentably distinct from claims in a first patent.”15 49. Patent prosecutions… original patent filings. However, for these secondary patent filings, the original patents become “prior…of AbbVie’s use patents and found three patents invalid due to obviousness: U.S. Patent No. 8,889,135;…two patents were invalid. 101. U.S. Patent No. 9,512,216 is no better than the patents for External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Moodys
Mallinckrodt
Citi
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.